blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3504210

EP3504210 - 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.12.2021
Database last updated on 12.07.2024
FormerThe patent has been granted
Status updated on  22.01.2021
FormerGrant of patent is intended
Status updated on  20.09.2020
FormerRequest for examination was made
Status updated on  28.07.2020
FormerGrant of patent is intended
Status updated on  17.05.2020
FormerRequest for examination was made
Status updated on  31.05.2019
FormerThe international publication has been made
Status updated on  10.03.2018
Formerunknown
Status updated on  08.09.2017
Most recent event   Tooltip03.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 05.06.2024  [2024/23]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2019/27]
Inventor(s)01 / GAO, Lu
Building 5 No. 720 Cailun Road
Shanghai 201203 / CN
02 / LIANG, Chungen
Building 5 No. 720 Cailun Road
Shanghai 201203 / CN
03 / YUN, Hongying
Building 5 No. 720 Cailun Road
Shanghai 201203 / CN
04 / ZHENG, Xiufang
Building 5 No. 720 Cailun Road
Shanghai 201203 / CN
05 / WANG, Jianping
Building 5 No. 720 Cailun Road
Shanghai 201203 / CN
06 / MIAO, Kun
Building 5 No. 720 Cailun Road
Shanghai 201203 / CN
07 / ZHANG, Bo
Building 5 No. 720 Cailun Road
Shanghai 201203 / CN
 [2019/27]
Representative(s)Bernard, Guillaume
F. Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[2019/27]
Application number, filing date17758527.028.08.2017
[2019/27]
WO2017EP71514
Priority number, dateWO2016CN9714029.08.2016         Original published format: PCT/CN2016/097140
WO2017CN9265312.07.2017         Original published format: PCT/CN2017/092653
[2019/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018041763
Date:08.03.2018
Language:EN
[2018/10]
Type: A1 Application with search report 
No.:EP3504210
Date:03.07.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 08.03.2018 takes the place of the publication of the European patent application.
[2019/27]
Type: B1 Patent specification 
No.:EP3504210
Date:24.02.2021
Language:EN
[2021/08]
Search report(s)International search report - published on:EP08.03.2018
ClassificationIPC:C07D473/24, A61K31/522, A61P31/00, A61P37/04, A61P43/00, A61P31/20
[2020/21]
CPC:
C07D473/24 (EP,IL,KR,RU,US); A61K31/522 (KR,RU); A61P31/00 (EP,IL,RU);
A61P31/20 (EP,IL,KR); A61P37/04 (EP,IL); A61P43/00 (EP,IL)
Former IPC [2019/27]C07D473/24, A61K31/522, A61P31/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/27]
Extension statesBANot yet paid
MENot yet paid
Validation statesMA29.03.2019
TitleGerman:7-SUBSTITUIERTE SULFONIMIDOYLPURINONVERBINDUNGEN ZUR BEHANDLUNG UND PROPHYLAXE VON VIRUSINFEKTIONEN[2019/27]
English:7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION[2019/27]
French:COMPOSÉS DE SULFONIMIDOYLPURINONE SUBSTITUÉS DANS LA POSITION 7 POUR LE TRAITEMENT ET LA PROPHYLAXIE D'INFECTION VIRALE[2019/27]
Entry into regional phase29.03.2019National basic fee paid 
29.03.2019Designation fee(s) paid 
29.03.2019Examination fee paid 
Examination procedure29.03.2019Examination requested  [2019/27]
29.03.2019Date on which the examining division has become responsible
18.10.2019Amendment by applicant (claims and/or description)
18.05.2020Communication of intention to grant the patent
28.07.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
21.09.2020Communication of intention to grant the patent
13.01.2021Fee for grant paid
13.01.2021Fee for publishing/printing paid
13.01.2021Receipt of the translation of the claim(s)
Divisional application(s)EP20207475.3  / EP3865482
Opposition(s)25.11.2021No opposition filed within time limit [2022/05]
Fees paidRenewal fee
08.08.2019Renewal fee patent year 03
17.08.2020Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL24.02.2021
CY24.02.2021
EE24.02.2021
LV24.02.2021
MC24.02.2021
MK24.02.2021
SM24.02.2021
IS24.06.2021
LU28.08.2021
[2024/23]
Former [2023/30]AL24.02.2021
CY24.02.2021
EE24.02.2021
LV24.02.2021
MC24.02.2021
SM24.02.2021
IS24.06.2021
LU28.08.2021
Former [2022/24]AL24.02.2021
EE24.02.2021
LV24.02.2021
MC24.02.2021
SM24.02.2021
IS24.06.2021
LU28.08.2021
Former [2022/18]AL24.02.2021
EE24.02.2021
LV24.02.2021
MC24.02.2021
SM24.02.2021
IS24.06.2021
Former [2022/07]AL24.02.2021
EE24.02.2021
LV24.02.2021
SM24.02.2021
IS24.06.2021
Former [2021/48]EE24.02.2021
LV24.02.2021
SM24.02.2021
IS24.06.2021
Former [2021/46]LV24.02.2021
SM24.02.2021
IS24.06.2021
Former [2021/42]LV24.02.2021
IS24.06.2021
Former [2021/37]LV24.02.2021
Cited inInternational search[A]WO2009005687  (GILEAD SCIENCES INC [US], et al);
 [AD]US2010143301  (DESAI MANOJ C [US], et al);
 [IP]WO2016180695  (HOFFMANN LA ROCHE [CH], et al)
by applicantJPH11193282
 US2010143301
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.